Literature DB >> 25997083

Nose-to-Brain Delivery: Investigation of the Transport of Nanoparticles with Different Surface Characteristics and Sizes in Excised Porcine Olfactory Epithelium.

Alpesh Mistry1, Snjezana Stolnik1, Lisbeth Illum2.   

Abstract

The ability to deliver therapeutically relevant amounts of drugs directly from the nasal cavity to the central nervous system to treat neurological diseases is dependent on the availability of efficient drug delivery systems. Increased delivery and/or therapeutic effect has been shown for drugs encapsulated in nanoparticles; however, the factors governing the transport of the drugs and/or the nanoparticles from the nasal cavity to the brain are not clear. The present study evaluates the potential transport of nanoparticles across the olfactory epithelium in relation to nanoparticle characteristics. Model systems, 20, 100, and 200 nm fluorescent carboxylated polystyrene (PS) nanoparticles that were nonmodified or surface modified with polysorbate 80 (P80-PS) or chitosan (C-PS), were assessed for transport across excised porcine olfactory epithelium mounted in a vertical Franz diffusion cell. Assessment of the nanoparticle content in the donor chamber of the diffusion cell, accompanied by fluorescence microscopy of dismounted tissues, revealed a loss of nanoparticle content from the donor suspension and their association with the excised tissue, depending on the surface properties and particle size. Chitosan surface modification of PS nanoparticles resulted in the highest tissue association among the tested systems, with the associated nanoparticles primarily located in the mucus, whereas the polysorbate 80-modified nanoparticles showed some penetration into the epithelial cell layer. Assessment of the bioelectrical properties, metabolic activity, and histology of the excised olfactory epithelium showed that C-PS nanoparticles applied in pH 6.0 buffer produced a damaging effect on the epithelial cell layer in a size-dependent manner, with fine 20 nm sized nanoparticles causing substantial tissue damage relative to that with the 100 and 200 nm counterparts. Although histology showed that the olfactory tissue was affected by the application of citrate buffer that was augmented by addition of chitosan in solution, this was not reflected in the bioelectrical parameters and the metabolic activity of the tissue. Regarding transport across the excised olfactory tissue, none of the nanoparticle systems tested, irrespective of particle size or surface modification, was transported across the epithelium to appear in measurable amounts in the receiver chamber.

Entities:  

Keywords:  chitosan; excised tissue; nose-to-brain delivery; olfactory epithelium; polysorbate 80; transepithelial transport

Mesh:

Year:  2015        PMID: 25997083     DOI: 10.1021/acs.molpharmaceut.5b00088

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  21 in total

Review 1.  Recent trends on hydrogel based drug delivery systems for infectious diseases.

Authors:  Arti Vashist; Ajeet Kaushik; Atul Vashist; Rahul Dev Jayant; Asahi Tomitaka; Sharif Ahmad; Y K Gupta; Madhavan Nair
Journal:  Biomater Sci       Date:  2016-10-18       Impact factor: 6.843

2.  Rutin-Loaded Solid Lipid Nanoparticles: Characterization and In Vitro Evaluation.

Authors:  Federica De Gaetano; Maria Chiara Cristiano; Valentina Venuti; Vincenza Crupi; Domenico Majolino; Giuseppe Paladini; Giuseppe Acri; Barbara Testagrossa; Alessia Irrera; Donatella Paolino; Silvana Tommasini; Cinzia Anna Ventura; Rosanna Stancanelli
Journal:  Molecules       Date:  2021-02-16       Impact factor: 4.411

3.  Nanomedicine strategy for optimizing delivery to outer hair cells by surface-modified poly(lactic/glycolic acid) nanoparticles with hydrophilic molecules.

Authors:  Xingxing Wen; Shan Ding; Hui Cai; Junyi Wang; Lu Wen; Fan Yang; Gang Chen
Journal:  Int J Nanomedicine       Date:  2016-11-10

4.  Optimization of Curcumin Nanocrystals as Promising Strategy for Nose-to-Brain Delivery Application.

Authors:  Angela Bonaccorso; Maria Rosa Gigliobianco; Rosalia Pellitteri; Debora Santonocito; Claudia Carbone; Piera Di Martino; Giovanni Puglisi; Teresa Musumeci
Journal:  Pharmaceutics       Date:  2020-05-23       Impact factor: 6.321

5.  Could the Olfactory System Be a Target for Homeopathic Remedies as Nanomedicines?

Authors:  Florence Courtens; Jean-Louis Demangeat; Mourad Benabdallah
Journal:  J Altern Complement Med       Date:  2018-06-11       Impact factor: 2.579

6.  Allogenic Fc Domain-Facilitated Uptake of IgG in Nasal Lamina Propria: Friend or Foe for Intranasal CNS Delivery?

Authors:  Simone Ladel; Johannes Flamm; Arghavan Soleimani Zadeh; Dorothea Filzwieser; Julia-Christina Walter; Patrick Schlossbauer; Ralf Kinscherf; Katharina Lischka; Harald Luksch; Katharina Schindowski
Journal:  Pharmaceutics       Date:  2018-07-26       Impact factor: 6.321

7.  Fate of nanoparticles in the central nervous system after intrathecal injection in healthy mice.

Authors:  K T Householder; S Dharmaraj; D I Sandberg; R J Wechsler-Reya; R W Sirianni
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379

8.  Crocetin as New Cross-Linker for Bioactive Sericin Nanoparticles.

Authors:  Sara Perteghella; Giovanna Rassu; Elisabetta Gavini; Antonella Obinu; Elia Bari; Delia Mandracchia; Maria Cristina Bonferoni; Paolo Giunchedi; Maria Luisa Torre
Journal:  Pharmaceutics       Date:  2021-05-09       Impact factor: 6.321

9.  Quality by Design Approach for the Development of Liposome Carrying Ghrelin for Intranasal Administration.

Authors:  Cecília de Barros; Norberto Aranha; Patrícia Severino; Eliana B Souto; Aleksandra Zielińska; André Lopes; Alessandra Rios; Fernando Batain; Kessi Crescencio; Marco Chaud; Thais Alves
Journal:  Pharmaceutics       Date:  2021-05-10       Impact factor: 6.321

Review 10.  Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting.

Authors:  Fabio Sonvico; Adryana Clementino; Francesca Buttini; Gaia Colombo; Silvia Pescina; Silvia Stanisçuaski Guterres; Adriana Raffin Pohlmann; Sara Nicoli
Journal:  Pharmaceutics       Date:  2018-03-15       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.